Survivorship Unit, Danish Cancer Society Research Center, Copenhagen, Denmark.
CASTLE Late Effects Unit, Department of Oncology, Copenhagen University Hospital Rigshospitalet, Copenhagen, Denmark.
Cancer. 2019 May 15;125(10):1683-1692. doi: 10.1002/cncr.31962. Epub 2019 Jan 11.
Existing research suggests that progressive resistance training (PRT) after breast cancer (BC) surgery is safe, but the preventive effect on arm lymphedema has yet to be determined.
Women aged 18 to 75 years who were undergoing BC surgery with axillary lymph node dissection were eligible for the study. Recruited on the day of surgery, participants were allocated to intervention or usual care by computer randomization. The intervention consisted of PRT 3 times per week: in the first 20 weeks as a supervised group exercise and in the last 30 weeks as a self-administered exercise. The primary outcome was arm lymphedema, which was defined as a >3% increase in the interlimb volume difference by water displacement. Measurements were made at the baseline and at a 12-month follow-up by physiotherapists blinded to group allocation. Analyses of effects included t tests and regression models; missing data were addressed by multiple imputation.
Among the 158 randomized women, no mean group difference was found in arm volume (0.3%; 95% confidence interval, -1.7% to 2.3%) or lymphedema incidence (adjusted odds ratio, 1.2; 95% confidence interval, 0.5-2.8). None of the participants exited the program because of adverse events.
This study provides no evidence that PRT can prevent arm lymphedema in the first year after BC, but the results corroborate the importance and safety of resistance training for patients, including women at high risk for lymphedema.
现有研究表明,乳腺癌(BC)手术后进行渐进式抗阻训练(PRT)是安全的,但对上肢淋巴水肿的预防作用尚未确定。
本研究纳入了年龄在 18 岁至 75 岁之间、接受腋窝淋巴结清扫术的 BC 手术患者。患者在手术当天入组,通过计算机随机分配至干预组或常规护理组。干预措施包括每周 3 次 PRT:前 20 周为监督下的团体运动,后 30 周为自行进行的运动。主要结局为上肢淋巴水肿,定义为肢体间体积差异增加>3%(通过排水法测量)。由对分组情况不知情的物理治疗师在基线和 12 个月随访时进行测量。采用 t 检验和回归模型进行效应分析;通过多重插补处理缺失数据。
在 158 名随机分配的女性中,手臂体积(0.3%;95%置信区间,-1.7%至 2.3%)或淋巴水肿发生率(调整后的优势比,1.2;95%置信区间,0.5-2.8)在两组间无平均差异。没有参与者因不良事件退出该方案。
本研究未发现 PRT 可在 BC 后 1 年内预防上肢淋巴水肿,但结果证实了阻力训练对患者的重要性和安全性,包括高淋巴水肿风险的女性。